1. MITF is a driver oncogene and potential therapeutic target in kidney angiomyolipoma tumors through transcriptional regulation of CYR61
   Mahsa Zarei et al, 2021, Oncogene CrossRef
2. Pro-metastatic functions of Notch signaling is mediated by CYR61 in breast cells
   Mustafa Ilhan et al, 2020, European Journal of Cell Biology CrossRef
3. Serum CYR61 as a potential biomarker to improve breast cancer diagnostics
   Zhen Lin et al, 2022, Biomarkers in Medicine CrossRef
4. Binding of the angiogenic/senescence inducer CCN1/CYR61 to integrin α6β1 drives endocrine resistance in breast cancer cells
   Ingrid Espinoza et al, 2022, Aging CrossRef
5. Overexpression of MCM10 promotes cell proliferation and predicts poor prognosis in prostate cancer
   Feilun Cui et al, 2018, The Prostate CrossRef
6. RU486 Metabolite Inhibits CCN1/Cyr61 Secretion by MDA-MB-231-Endothelial Adhesion
   Suhong Yu et al, 2019, Frontiers in Pharmacology CrossRef
7. An EZH2-NF-κB regulatory axis drives expression of pro-oncogenic gene signatures in triple negative breast cancer
   Gabrielle J. Dardis et al, 2023, iScience CrossRef